- Global Pharma News & Resources

Topical Pain Relief Market to Reach $13.28 Billion at 7.4% CAGR Globally by 2025

Increase in geriatric population and rise in prevalence of arthritis drive the growth of the market. Moreover, high demand for topical pain relievers among athletes and lesser side effects as compared to conventional oral medicines supplement the market growth. However, side effects such as skin irritation restrain the growth of the market. On the other hand, proliferation of online pharmacy and untapped potential in emerging nations offer new opportunities to the industry.

Topical Pain Relief Market by Therapeutic Class (Non-Opioids and Opioids), Type (Prescription Pain Relief and Over-the-Counter Pain Relief), Formulation (Cream, Gel, Spray, Patch, and Others) and Distribution Channel (Pharmacies & Drug Stores, e-Commerce, and Retail & Grocery Stores) – Global Opportunity Analysis and Industry Forecast, 2018-2025. The report offers a detailed analysis of the industry dynamics, top player positioning, market size & forecasts, key market segments, and competitive landscape. According to the report, the global topical pain relief market garnered $7.48 billion in 2017, and is expected to reach $13.28 billion by 2025, growing at a CAGR of 7.4% from 2018 to 2025.

Download Sample PDF Of Report@

Leading market players:-

The leading market players analyzed in the report include Johnson & Johnson, GlaxoSmithKline Plc., Novartis AG, Reckitt Benckiser Group Plc., Pfizer Inc., Topical BioMedics, Inc., Sanofi S.A., Sun Pharmaceutical Industries Ltd., AdvaCare Pharma, and Nestle S.A. These players have implemented different strategies including partnerships, expansions, mergers & acquisitions, joint ventures, collaborations, and others to gain a strong position in the industry.

Over-the-counter pain relief segment to lead in terms of revenue & growth rate by 2025:-

Over-the-counter pain relief segment contributed more than half of the total market share in 2017 and is expected to continue its lead in terms of revenue by 2025. In addition, this segment would grow at the highest CAGR of 8.0% from 2018 to 2025, owing to lower cost and ease of availability as compared to counter pain relief products. Moreover, the prescription pain relief segment is expected to grow at a steady rate during the forecast period.

Topical pain relief cream segment to retain lion’s share through 2025 :-

Topical pain relief cream segment contributed nearly two-fifths share of the total revenue in 2017, and it is expected to retain its leadership position by 2025. This is attributed to its ability to offer long-lasting comfort and fast pain relief alongside reducing side effects and skin irritation. However, patch would register the highest CAGR of 9.0% from 2018 to 2025, owing to its ability to provide controlled absorption and uniform plasma drug concentrations to provide instant relief. The research also analyzes gel, spray, and others segments.

Non-opioids to be lucrative through 2025: –

Non-opioids segment accounted for nearly three-fourths share of the total market in 2017 and is expected to maintain its dominance throughout the forecast period. Moreover, this segment would register the highest CAGR of 7.6% from 2018 to 2025, as non-opioids exhibit fewer side effects as compared to opioids. The opioids segment is projected to grow at a steady rate during the forecast period.

E-commerce segment to register the highest growth rate by 2025: –

E-commerce is projected to be the fastest growing segment, registering a CAGR of 10.0% from 2018 to 2025 due to significant increase in digital literacy among the global population. However, pharmacies and drug stores segment accounted for the major market share in 2017, contributing nearly four-fifths share of the global market revenue. This segment is expected to remain dominant throughout the forecast period. In addition, the retail & grocery stores segment would register a steady growth rate during the forecast period.

Asia-Pacific to grow the fastest through 2025:-

Rise in prevalence of chronic diseases including cancer, arthritis, and diabetes among others coupled with increase in investments by various multinational companies would enable the Asia-Pacific region to grow at the fastest CAGR of 8.6% from 2018 to 2025. However, North America held the major share in 2017, accounting for more than one-third share due to increase in geriatric population, rise in per capita income, shift in focus of manufacturers toward topical pain relief products, and growth in awareness among population.

Inquiry For Buying This Report@

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060

This content has been distributed via WiredRelease press release distribution service. For press release service enquiry, please reach us at

Editor Details

Last Updated: 14-Feb-2020